Physician profile
Andrew Carbone
NPI 1396108460
$89,594.06
in general payments reported to CMS, 2019-2025
18 companies · $2,494 in 2025
The $2,494 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $341 · 2021: $31K · 2022: $28K · 2023: $17K · 2024: $10K · 2025: $2,494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Education: $8,755 · Travel and Lodging: $5,738 · Food and Beverage: $5,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Education | $8,754.76 |
| Travel and Lodging | $5,737.88 |
| Food and Beverage | $5,285.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $38,700.88 | 2021-2025 | |
| Smith+Nephew, INC. | $14,908.08 | 2021-2025 | Healicoil, Q-Fix, Bone Anchors With Arthroscopic Delivery System |
| Stryker Corporation | $12,160.89 | 2021-2025 | Mako, Salvation, Inspace |
| Medwest Associates | $8,319.90 | 2021-2022 | |
| Micromed INC | $6,128.06 | 2021-2022 | |
| Medical Device Business Services, INC. | $4,306.16 | 2021-2024 | Rigidloop |
| Saxum Surgical, INC. | $3,605.68 | 2022 | |
| Medtronic USA, INC. | $341.28 | 2020 | |
| Depuy Synthes Sales INC. | $313.30 | 2022-2024 | Milagro, Orthovisc, Monovisc |
| Reel Surgical, INC. | $161.54 | 2024 | |
| Linvatec Corporation | $147.47 | 2024-2025 | Biobrace 23mm |
| Sanara Medtech INC. | $139.79 | 2024 | Celleraterx |
| Oak Med, INC. | $120.37 | 2024 | |
| Catalyst Orthoscience | $84.38 | 2021 | |
| Zimmer Biomet Holdings, INC. | $63.88 | 2025 | Juggerknotless Soft Anchor |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $56.30 | 2022 | |
| Bioventus LLC | $20.27 | 2022 | |
| Zimvie INC. | $15.83 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Carbone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.